cdcgov/jaspr repository overview

⁠JASPR

⁠Container Image Quick Access

Use the published JASPR container image from Docker Hub without checking out source code.

JASPR is a curve-fitting and report-generation application for antigenic assay analysis used in viral surveillance workflows. Supported workflows include high content imaging-based neutralization test (HINT) (Gubareva et al., 2019), Infected Cell Population (ICP) (Gubareva et al., 2019), and Focus Reduction Neutralization Test (FRNT) (Suthar et al., 2020).

export FULL_IMAGE=docker.io/cdcgov/jaspr:latest

⁠Pull and Run on Another Machine

Run with Docker:

docker pull $FULL_IMAGE
docker run -d --name jaspr -p 80:80 -p 443:443 $FULL_IMAGE

Run with Podman:

podman pull $FULL_IMAGE
podman run -d --name jaspr -p 80:80 -p 443:443 $FULL_IMAGE

Then open either:

http://localhost
https://localhost

If the browser shows "Your connection isn't private" for https://localhost, open Advanced and choose Proceed to localhost.

⁠Optional High-Port Mode

If your runtime/user is not allowed to bind to standard web ports, use high ports instead:

docker run -d --name jaspr -p 8080:80 -p 8443:443 $FULL_IMAGE
podman run -d --name jaspr -p 8080:80 -p 8443:443 $FULL_IMAGE

Then open either:

http://localhost:8080
https://localhost:8443

Using 8080 and 8443 avoids privileged-port issues that are common with rootless Podman and some locked-down Docker environments.

If the browser shows "Your connection isn't private" for https://localhost:8443, open Advanced and choose Proceed to localhost.

⁠Stop the Container

docker stop jaspr && docker rm jaspr
podman stop jaspr && podman rm jaspr

References: Jorquera PA, Mishin VP, Chesnokov A, et al.; Gubareva LV. (2019). Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018. Scientific Reports, 9(1). DOI: 10.1038/s41598-019-39276-1. Vanderheiden A, Edara VV, Floyd K, et al.; Suthar MS. (2020). Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies. Current Protocols in Immunology, 131(1), e116. DOI: 10.1002/cpim.116.